3-(1H-benzimidazol-2-yl)-5-phenylsulfanyl-pyrazin-2-amine | 1349686-98-1

• 分子结构分类: 有机化合物 - 有机硫化合物 - 硫醚类
• 英文名称: 3-(1H-benzimidazol-2-yl)-5-phenylsulfanyl-pyrazin-2-amine
• 英文别名: 3-(1H-benzimidazol-2-yl)-5-phenylsulfanylpyrazin-2-amine
• CAS: 1349686-98-1
• 化学式: C₁₇H₁₃N₅S
• 分子量: 319.39
• InChiKey: NEMPMIRDQKRNPH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  23
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  106
• 氢给体数：
  2
• 氢受体数：
  5

文献信息

• [EN] PYRAZINES USEFUL AS INHIBITORS OF ATR KINASE<br/>[FR] PYRAZINES UTILES EN TANT QU'INHIBITEURS DE LA KINASE ATR
  申请人：VERTEX PHARMA

  公开号：WO2011143419A1

  公开（公告）日：2011-11-17

  The present invention relates to pyrazine compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors. The compounds of this invention have formula II; (Formula (II) wherein the variables are as defined herein.

  本发明涉及用作ATR蛋白激酶抑制剂的吡嗪化合物。该发明还涉及包括本发明化合物的药学上可接受的组合物；使用本发明化合物治疗各种疾病、疾病和症状的方法；制备本发明化合物的方法；制备本发明化合物的中间体；以及在体外应用中使用化合物的方法，例如在生物和病理现象中研究激酶；通过这些激酶介导的细胞内信号传导途径的研究；以及新激酶抑制剂的比较评估。本发明的化合物具有II式；（式（II）其中变量如本文所定义。
• COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE
  申请人：Charrier Jean-Damien

  公开号：US20120035407A1

  公开（公告）日：2012-02-09

  The present invention relates to pyrazine compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors. The compounds of this invention have formula II: wherein the variables are as defined herein.

  本发明涉及用作ATR蛋白激酶抑制剂的吡嗪化合物。本发明还涉及包含本发明化合物的药学上可接受的组合物；使用本发明化合物治疗各种疾病、障碍和病况的方法；制备本发明化合物的方法；制备本发明化合物的中间体；以及在体外应用中使用化合物的方法，例如研究生物和病理现象中的激酶、介导这些激酶的细胞内信号转导途径的研究，以及新的激酶抑制剂的比较评价。本发明化合物具有公式II：其中变量如本文所定义。
• PYRAZINES USEFUL AS INHIBITORS OF ATR KINASE
  申请人：Vertex Pharmaceuticals Incorporated

  公开号：EP2569289A1

  公开（公告）日：2013-03-20
• US8962631B2
  申请人：——

  公开号：US8962631B2

  公开（公告）日：2015-02-24